Literature DB >> 29917052

Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.

Anna-Kaisa Ruotsalainen1, Jari P Lappalainen1,2, Emmi Heiskanen1, Mari Merentie1, Virve Sihvola1, Juha Näpänkangas3, Line Lottonen-Raikaslehto1, Emilia Kansanen1, Simone Adinolfi1, Kai Kaarniranta4, Seppo Ylä-Herttuala1,5, Matti Jauhiainen6,7, Eija Pirinen8, Anna-Liisa Levonen1.   

Abstract

Aims: Oxidative stress and inflammation play an important role in the progression of atherosclerosis. Transcription factor NF-E2-related factor 2 (Nrf2) has antioxidant and anti-inflammatory effects in the vessel wall, but paradoxically, global loss of Nrf2 in apoE deficient mice alleviates atherosclerosis. In this study, we investigated the effect of global Nrf2 deficiency on early and advanced atherogenesis in alternative models of atherosclerosis, LDL receptor deficient mice (LDLR-/-), and LDLR-/- mice expressing apoB-100 only (LDLR-/- ApoB100/100) having a humanized lipoprotein profile. Methods and results: LDLR-/- mice were fed a high-fat diet (HFD) for 6 or 12 weeks and LDLR-/-ApoB100/100 mice a regular chow diet for 6 or 12 months. Nrf2 deficiency significantly reduced early and more advanced atherosclerosis assessed by lesion size and coverage in the aorta in both models. Nrf2 deficiency in LDLR-/- mice reduced total plasma cholesterol after 6 weeks of HFD and triglycerides in LDLR-/-ApoB100/100 mice on a chow diet. Nrf2 deficiency aggravated aortic plaque maturation in aged LDLR-/-ApoB100/100 mice as it increased plaque calcification. Moreover, ∼36% of Nrf2-/-LDLR-/-ApoB100/100 females developed spontaneous myocardial infarction (MI) or sudden death at 5 to 12 months of age. Interestingly, Nrf2 deficiency increased plaque instability index, enhanced plaque inflammation and calcification, and reduced fibrous cap thickness in brachiocephalic arteries of LDLR-/-ApoB100/100 female mice at age of 12 months. Conclusions: Absence of Nrf2 reduced atherosclerotic lesion size in both atherosclerosis models, likely via systemic effects on lipid metabolism. However, Nrf2 deficiency in aged LDLR-/-ApoB100/100 mice led to an enhanced atherosclerotic plaque instability likely via increased plaque inflammation and oxidative stress, which possibly predisposed to MI and sudden death.

Entities:  

Year:  2019        PMID: 29917052     DOI: 10.1093/cvr/cvy143

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  12 in total

Review 1.  Targeting Mechanosensitive Transcription Factors in Atherosclerosis.

Authors:  Niu Niu; Suowen Xu; Yanni Xu; Peter J Little; Zheng-Gen Jin
Journal:  Trends Pharmacol Sci       Date:  2019-02-28       Impact factor: 14.819

2.  Reciprocal regulation of NRF2 by autophagy and ubiquitin-proteasome modulates vascular endothelial injury induced by copper oxide nanoparticles.

Authors:  Na Li; Hang Du; Lejiao Mao; Ge Xu; Mengling Zhang; Yinzhen Fan; Xiaomei Dong; Lijun Zheng; Bin Wang; Xia Qin; Xuejun Jiang; Chengzhi Chen; Zhen Zou; Jun Zhang
Journal:  J Nanobiotechnology       Date:  2022-06-11       Impact factor: 9.429

3.  Complement Factor H and Apolipoprotein E Participate in Regulation of Inflammation in THP-1 Macrophages.

Authors:  Eija Nissilä; Pipsa Hakala; Katarzyna Leskinen; Angela Roig; Shahan Syed; Kok P M Van Kessel; Jari Metso; Carla J C De Haas; Päivi Saavalainen; Seppo Meri; Angeliki Chroni; Jos A G Van Strijp; Katariina Öörni; Matti Jauhiainen; T Sakari Jokiranta; Karita Haapasalo
Journal:  Front Immunol       Date:  2018-11-21       Impact factor: 7.561

4.  CFTR Deletion Confers Mitochondrial Dysfunction and Disrupts Lipid Homeostasis in Intestinal Epithelial Cells.

Authors:  Marie L Kleme; Alain Sané; Carole Garofalo; Ernest Seidman; Emmanuelle Brochiero; Yves Berthiaume; Emile Levy
Journal:  Nutrients       Date:  2018-06-27       Impact factor: 5.717

Review 5.  Senescent Cells in Early Vascular Ageing and Bone Disease of Chronic Kidney Disease-A Novel Target for Treatment.

Authors:  Sam Hobson; Samsul Arefin; Karolina Kublickiene; Paul G Shiels; Peter Stenvinkel
Journal:  Toxins (Basel)       Date:  2019-02-01       Impact factor: 4.546

Review 6.  The Role of Natural Products in Targeting Cardiovascular Diseases via Nrf2 Pathway: Novel Molecular Mechanisms and Therapeutic Approaches.

Authors:  Bee Kee Ooi; Kok-Gan Chan; Bey Hing Goh; Wei Hsum Yap
Journal:  Front Pharmacol       Date:  2018-11-15       Impact factor: 5.810

7.  Loss of exosomal MALAT1 from ox-LDL-treated vascular endothelial cells induces maturation of dendritic cells in atherosclerosis development.

Authors:  Hongqi Li; Xiang Zhu; Liqun Hu; Qing Li; Jian Ma; Ji Yan
Journal:  Cell Cycle       Date:  2019-07-29       Impact factor: 4.534

Review 8.  Targeting non-coding RNAs in unstable atherosclerotic plaques: Mechanism, regulation, possibilities, and limitations.

Authors:  Xiaoxin Li; Yanyan Yang; Zhibin Wang; Shaoyan Jiang; Yuanyuan Meng; Xiaoxia Song; Liang Zhao; Lu Zou; Min Li; Tao Yu
Journal:  Int J Biol Sci       Date:  2021-08-03       Impact factor: 6.580

Review 9.  Nrf2 for cardiac protection: pharmacological options against oxidative stress.

Authors:  Qin M Chen
Journal:  Trends Pharmacol Sci       Date:  2021-07-28       Impact factor: 17.638

Review 10.  Genetic Variations on Redox Control in Cardiometabolic Diseases: The Role of Nrf2.

Authors:  Cecilia Zazueta; Alexis Paulina Jimenez-Uribe; José Pedraza-Chaverri; Mabel Buelna-Chontal
Journal:  Antioxidants (Basel)       Date:  2022-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.